103 related articles for article (PubMed ID: 1831399)
1. Isolated incisional metastases after intraperitoneal radioactive chromic phosphate therapy for ovarian carcinoma.
Kohler MF; Soper JT; Tucker JA; Clarke-Pearson DL
Cancer; 1991 Sep; 68(6):1380-3. PubMed ID: 1831399
[TBL] [Abstract][Full Text] [Related]
2. Intraperitoneal radioactive phosphorus (32P) versus observation after negative second-look laparotomy for stage III ovarian carcinoma: a randomized trial of the Gynecologic Oncology Group.
Varia MA; Stehman FB; Bundy BN; Benda JA; Clarke-Pearson DL; Alvarez RD; Long HJ;
J Clin Oncol; 2003 Aug; 21(15):2849-55. PubMed ID: 12885800
[TBL] [Abstract][Full Text] [Related]
3. Second-look laparotomy after chemotherapy in the management of ovarian malignancy.
Smirz LR; Stehman FB; Ulbright TM; Sutton GP; Ehrlich CE
Am J Obstet Gynecol; 1985 Jul; 152(6 Pt 1):661-8. PubMed ID: 4040706
[TBL] [Abstract][Full Text] [Related]
4. Intraperitoneal chromic phosphate therapy after second-look laparotomy for ovarian cancer.
Varia M; Rosenman J; Venkatraman S; Askin F; Fowler W; Walton L; Halle J; Currie J
Cancer; 1988 Mar; 61(5):919-27. PubMed ID: 3338057
[TBL] [Abstract][Full Text] [Related]
5. Intraperitoneal chromic phosphate P 32 as salvage therapy for persistent carcinoma of the ovary after surgical restaging.
Soper JT; Wilkinson RH; Bandy LC; Clarke-Pearson DL; Creasman WT
Am J Obstet Gynecol; 1987 May; 156(5):1153-8. PubMed ID: 3578429
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant intraperitoneal chromic phosphate therapy for women with apparent early ovarian carcinoma who have not undergone comprehensive surgical staging.
Soper JT; Berchuck A; Clarke-Pearson DL
Cancer; 1991 Aug; 68(4):725-9. PubMed ID: 1855171
[TBL] [Abstract][Full Text] [Related]
7. Intravenous chemotherapy, early debulking surgery, and consolidation intraperitoneal chemotherapy in advanced ovarian carcinoma.
Tournigand C; Louvet C; Molitor JL; Dehni N; Lejeune V; Sezeur A; Pigne A; Marpeau L; Cady J; de Gramont A
Gynecol Oncol; 2001 Nov; 83(2):198-204. PubMed ID: 11606072
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant treatment for early ovarian cancer: a randomized phase III trial of intraperitoneal 32P or intravenous cyclophosphamide and cisplatin--a gynecologic oncology group study.
Young RC; Brady MF; Nieberg RK; Long HJ; Mayer AR; Lentz SS; Hurteau J; Alberts DS
J Clin Oncol; 2003 Dec; 21(23):4350-5. PubMed ID: 14645424
[TBL] [Abstract][Full Text] [Related]
9. Chromic phosphate therapy in carcinoma of the ovary.
Goodman A; Bornstein L; Ball H; Smith DM; Bankoff M
J Am Coll Surg; 1994 Oct; 179(4):401-6. PubMed ID: 7921388
[TBL] [Abstract][Full Text] [Related]
10. Perforating cutaneous metastasis from an ovarian adenocarcinoma.
Abbas O; Salem Z; Haddad F; Kibbi AG
J Cutan Pathol; 2010 Sep; 37(9):e53-6. PubMed ID: 19615029
[TBL] [Abstract][Full Text] [Related]
11. Intraperitoneal P-32 after negative second-look laparotomy in ovarian carcinoma.
Spencer TR; Marks RD; Fenn JO; Jenrette JM; Lutz MH
Cancer; 1989 Jun; 63(12):2434-7. PubMed ID: 2720591
[TBL] [Abstract][Full Text] [Related]
12. Peritonectomy and hyperthermic chemotherapy in patients with advanced or recurrent ephitelial ovarian cancer: a single center cohort study.
Massari R; Barone M; Basilico R; Carella C; Colasante A; De Tursi M; Filippone A; Guetti L; Mani A
Minerva Chir; 2014 Feb; 69(1):17-26. PubMed ID: 24675243
[TBL] [Abstract][Full Text] [Related]
13. Intraperitoneal radioactive phosphorus therapy in ovarian carcinoma. Analysis of 313 patients treated primarily or at second-look laparotomy.
Vergote IB; Winderen M; De Vos LN; Tropé CG
Cancer; 1993 Apr; 71(7):2250-60. PubMed ID: 8453546
[TBL] [Abstract][Full Text] [Related]
14. Treatment of peritoneal carcinomatosis from ovarian cancer by surgical cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC).
Robella M; Vaira M; Marsanic P; Mellano A; Borsano A; Cinquegrana A; Sottile A; De Simone M
Minerva Chir; 2014 Feb; 69(1):27-35. PubMed ID: 24675244
[TBL] [Abstract][Full Text] [Related]
15. Use of P-32 in stage III epithelial carcinoma of the ovary.
Spanos WJ; Day T; Jose B; Paris K; Lindberg RD
Gynecol Oncol; 1994 Jul; 54(1):35-9. PubMed ID: 8020836
[TBL] [Abstract][Full Text] [Related]
16. Abdominopelvic irradiation for persistent advanced ovarian carcinoma.
Stephenson JA; Buchler DA
Int J Radiat Oncol Biol Phys; 1989 Aug; 17(2):385-8. PubMed ID: 2753763
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant therapy with intraperitoneal chromic phosphate (32P) in women with early ovarian carcinoma after comprehensive surgical staging.
Soper JT; Berchuck A; Dodge R; Clarke-Pearson DL
Obstet Gynecol; 1992 Jun; 79(6):993-7. PubMed ID: 1579329
[TBL] [Abstract][Full Text] [Related]
18. Phosphorus-32-chromic phosphate for ovarian cancer: I. Fractionated low-dose intraperitoneal treatments in conjunction with platinum analog chemotherapy.
Pattillo RA; Collier BD; Abdel-Dayem H; Ozker K; Wilson C; Ruckert AC; Hamilton K
J Nucl Med; 1995 Jan; 36(1):29-36. PubMed ID: 7799078
[TBL] [Abstract][Full Text] [Related]
19. Intraperitoneal cisplatin and paclitaxel in ovarian cancer.
Armstrong DK; Bundy B; Wenzel L; Huang HQ; Baergen R; Lele S; Copeland LJ; Walker JL; Burger RA;
N Engl J Med; 2006 Jan; 354(1):34-43. PubMed ID: 16394300
[TBL] [Abstract][Full Text] [Related]
20. [A case of delayed subcutaneous metastases of gastric carcinoma effectively treated with S-1 plus cisplatin chemotherapy].
Matsuoka T; Hosaka S; Inada K; Kawamoto S
Gan To Kagaku Ryoho; 2013 Nov; 40(12):2262-4. PubMed ID: 24394079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]